31 July 206

Here’s a snippet..

Yet despite Israel’s research, its medical cannabis program is narrow: Only 25,000 patients have government-issued “licenses” to use cannabis, and qualify after a difficult process of proving that several other pharmaceutical drugs have failed them. (To give some context: That’s about .3 percent of Israel’s population of 8 million. California has nearly 760,000 patients, accounting for 1.9 percent of its 40 million residents.) Israel’s medical program is so small because the plant still has “the stigma of hashish,” says S. David Moche, president of the America Israel Cannabis Association (AICA), which promotes dialogue between both countries.

Read The Full Article At